外体递送的生物活性分子调节动脉样硬化和心肌梗塞中的巨细胞极化:机制和治疗潜力
Yuanlin Zhou1, Guanghe Ran2, Hua Guo1
1Department of Cardiology Dandong Central Hospital, Liaoning, China.
Frontiers in cardiovascular medicine
|March 9, 2026
概括
外体调节巨细胞的两极分化,影响动脉样硬化和心脏修复. 本综述详细介绍了它们的机制和心血管疾病的治疗潜力.
科学领域:
- 细胞生物学 细胞生物学
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
背景情况:
- 外体通过活性分子调解细胞间的通信.
- 巨细胞两极分化对于动脉样硬化和心肌梗塞的修复至关重要.
- 外体细胞显著影响巨细胞极化动态.
研究的目的:
- 系统地审查调节巨细胞M1/M2极化的外体分子机制.
- 阐明外体在动脉样硬化 (AS) 和心肌梗塞 (MI) 中的双重作用.
- 讨论基于外体的生物标志物和心血管疾病治疗的临床潜力和挑战.
主要方法:
- 文献综述侧重于外体和巨细胞相互作用的分子机制.
- 对研究外体组在AS和MI病理生理学中的作用的分析.
- 对工程外体和药物输送系统的当前研究进行了审查.
主要成果:
- 外体细胞通过特定的分子载荷精确调节巨细胞的两极分化.
- 外基因组具有双重作用,可以促进或抑制AS和MI的进展.
- 工程外体和基于外体的药物载体显示出对心血管疾病治疗的希望.
结论:
- 外体是巨细胞两极分化的关键调节者,对心血管健康有重大影响.
- 了解外体机制为动脉样硬化和心肌梗塞提供了新的治疗途径.
- 对于心血管疾病管理,需要进一步的研究和基于外体的策略的临床翻译.
相关概念视频
Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
Inflammation
63.3K
Overview
63.3K
Atherosclerosis III: Management
541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541


